European Union -
English -
EMA (European Medicines Agency)
duloxetine boehringer ingelheim
boehringer ingelheim international gmbh - duloxetine - diabetic neuropathies - psychoanaleptics, - treatment of diabetic peripheral neuropathic pain in adults.
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
beromun 1mg powder and solvent for solution for infusion vials
boehringer ingelheim ltd - tasonermin - powder and solvent for solution for infusion - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
beromun 1mg powder for solution for infusion vials
boehringer ingelheim ltd - tasonermin - powder for solution for infusion - 1mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
praxbind 2.5g50ml solution for infusion vials
boehringer ingelheim ltd - idarucizumab - solution for infusion - 50mg/1ml
European Union -
English -
EMA (European Medicines Agency)
onduarp
boehringer ingelheim international gmbh - telmisartan - hypertension - cardiovascular system - treatment of essential hypertension in adults:add on therapyonduarp is indicated in adults whose blood pressure is not adequately controlled on amlodipine.replacement therapyadult patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of onduarp containing the same component doses.
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
vargatef 100mg capsules
boehringer ingelheim ltd - nintedanib esilate - capsule - 100mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
vargatef 150mg capsules
boehringer ingelheim ltd - nintedanib esilate - capsule - 150mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ofev 100mg capsules
boehringer ingelheim ltd - nintedanib esilate - capsule - 100mg
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ofev 150mg capsules
boehringer ingelheim ltd - nintedanib esilate - capsule - 150mg
European Union -
English -
EMA (European Medicines Agency)
cyltezo
boehringer ingelheim international gmbh - adalimumab - hidradenitis suppurativa; arthritis, psoriatic; psoriasis; crohn disease; arthritis, juvenile rheumatoid; uveitis; arthritis, rheumatoid; colitis, ulcerative; spondylitis, ankylosing - immunosuppressants - please refer to section 4.1 of the summary of product characteristics in the product information document.,